Literature DB >> 21047684

Unique biological function of cathepsin L in secretory vesicles for biosynthesis of neuropeptides.

Lydiane Funkelstein1, Margery Beinfeld, Ardalan Minokadeh, James Zadina, Vivian Hook.   

Abstract

Neuropeptides are essential for cell-cell communication in the nervous and neuroendocrine systems. Production of active neuropeptides requires proteolytic processing of proneuropeptide precursors in secretory vesicles that produce, store, and release neuropeptides that regulate physiological functions. This review describes recent findings indicating the prominent role of cathepsin L in secretory vesicles for production of neuropeptides from their protein precursors. The role of cathepsin L in neuropeptide production was discovered using the strategy of activity-based probes for proenkephalin-cleaving activity for identification of the enzyme protein by mass spectrometry. The novel role of cathepsin L in secretory vesicles for neuropeptide production has been demonstrated in vivo by cathepsin L gene knockout studies, cathepsin L gene expression in neuroendocrine cells, and notably, cathepsin L localization in neuropeptide-containing secretory vesicles. Cathepsin L is involved in producing opioid neuropeptides consisting of enkephalin, β-endorphin, and dynorphin, as well as in generating the POMC-derived peptide hormones ACTH and α-MSH. In addition, NPY, CCK, and catestatin neuropeptides utilize cathepsin L for their biosynthesis. The neuropeptide-synthesizing functions of cathepsin L represent its unique activity in secretory vesicles, which contrasts with its role in lysosomes. Interesting evaluations of protease gene knockout studies in mice that lack cathepsin L compared to those lacking PC1/3 and PC2 (PC, prohormone convertase) indicate the key role of cathepsin L in neuropeptide production. Therefore, dual cathepsin L and prohormone convertase protease pathways participate in neuropeptide production. Significantly, the recent new findings indicate cathepsin L as a novel 'proprotein convertase' for production of neuropeptides that mediate cell-cell communication in health and disease.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21047684      PMCID: PMC3058267          DOI: 10.1016/j.npep.2010.08.003

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  57 in total

1.  Galanin transgenic mice display cognitive and neurochemical deficits characteristic of Alzheimer's disease.

Authors:  R A Steiner; J G Hohmann; A Holmes; C C Wrenn; G Cadd; A Juréus; D K Clifton; M Luo; M Gutshall; S Y Ma; E J Mufson; J N Crawley
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-20       Impact factor: 11.205

2.  Historical review: Opioid receptors.

Authors:  Solomon H Snyder; Gavril W Pasternak
Journal:  Trends Pharmacol Sci       Date:  2003-04       Impact factor: 14.819

Review 3.  Precursor convertases in the secretory pathway, cytosol and extracellular milieu.

Authors:  Nabil G Seidah; Annik Prat
Journal:  Essays Biochem       Date:  2002       Impact factor: 8.000

Review 4.  Role of hypothalamic neuropeptide Y in feeding and obesity.

Authors:  D R Gehlert
Journal:  Neuropeptides       Date:  1999-10       Impact factor: 3.286

Review 5.  Processing and activation of lysosomal proteinases.

Authors:  Kazumi Ishidoh; Eiki Kominami
Journal:  Biol Chem       Date:  2002-12       Impact factor: 3.915

Review 6.  Furin at the cutting edge: from protein traffic to embryogenesis and disease.

Authors:  Gary Thomas
Journal:  Nat Rev Mol Cell Biol       Date:  2002-10       Impact factor: 94.444

7.  Inhibitory specificity and potency of proSAAS-derived peptides toward proprotein convertase 1.

Authors:  A Basak; P Koch; M Dupelle; L D Fricker; L A Devi; M Chrétien; N G Seidah
Journal:  J Biol Chem       Date:  2001-07-02       Impact factor: 5.157

8.  Pronociceptive actions of dynorphin maintain chronic neuropathic pain.

Authors:  Z Wang; L R Gardell; M H Ossipov; T W Vanderah; M B Brennan; U Hochgeschwender; V J Hruby; T P Malan; J Lai; F Porreca
Journal:  J Neurosci       Date:  2001-03-01       Impact factor: 6.167

Review 9.  The role of NPY in metabolic homeostasis: implications for obesity therapy.

Authors:  H A Wieland; B S Hamilton; B Krist; H N Doods
Journal:  Expert Opin Investig Drugs       Date:  2000-06       Impact factor: 6.206

10.  Effects of chromogranin A deficiency and excess in vivo: biphasic blood pressure and catecholamine responses.

Authors:  Sucheta M Vaingankar; Ying Li; Nilima Biswas; Jiaur Gayen; Sonia Choksi; Fangwen Rao; Michael G Ziegler; Sushil K Mahata; Daniel T O'Connor
Journal:  J Hypertens       Date:  2010-04       Impact factor: 4.844

View more
  19 in total

1.  On the cutting edge of proprotein convertase pharmacology: from molecular concepts to clinical applications.

Authors:  Frédéric Couture; François D'Anjou; Robert Day
Journal:  Biomol Concepts       Date:  2011-10-01

Review 2.  Neuropeptidomics Mass Spectrometry Reveals Signaling Networks Generated by Distinct Protease Pathways in Human Systems.

Authors:  Vivian Hook; Nuno Bandeira
Journal:  J Am Soc Mass Spectrom       Date:  2015-10-19       Impact factor: 3.109

3.  Identification of a broad-spectrum antiviral small molecule against severe acute respiratory syndrome coronavirus and Ebola, Hendra, and Nipah viruses by using a novel high-throughput screening assay.

Authors:  Hatem A Elshabrawy; Jilao Fan; Christine S Haddad; Kiira Ratia; Christopher C Broder; Michael Caffrey; Bellur S Prabhakar
Journal:  J Virol       Date:  2014-02-05       Impact factor: 5.103

4.  Design of Gallinamide A Analogs as Potent Inhibitors of the Cysteine Proteases Human Cathepsin L and Trypanosoma cruzi Cruzain.

Authors:  Paul D Boudreau; Bailey W Miller; Laura-Isobel McCall; Jehad Almaliti; Raphael Reher; Ken Hirata; Thu Le; Jair L Siqueira-Neto; Vivian Hook; William H Gerwick
Journal:  J Med Chem       Date:  2019-10-04       Impact factor: 7.446

Review 5.  Cysteine Cathepsins in the secretory vesicle produce active peptides: Cathepsin L generates peptide neurotransmitters and cathepsin B produces beta-amyloid of Alzheimer's disease.

Authors:  Vivian Hook; Lydiane Funkelstein; Jill Wegrzyn; Steven Bark; Mark Kindy; Gregory Hook
Journal:  Biochim Biophys Acta       Date:  2011-09-08

6.  The ubiquitin ligase Mindbomb 1 coordinates gastrointestinal secretory cell maturation.

Authors:  Benjamin J Capoccia; Ramon U Jin; Young-Yun Kong; Richard M Peek; Matteo Fassan; Massimo Rugge; Jason C Mills
Journal:  J Clin Invest       Date:  2013-03-08       Impact factor: 14.808

Review 7.  Cysteine cathepsins in neurological disorders.

Authors:  Anja Pišlar; Janko Kos
Journal:  Mol Neurobiol       Date:  2013-11-15       Impact factor: 5.590

Review 8.  The Emerging Role of Spinal Dynorphin in Chronic Pain: A Therapeutic Perspective.

Authors:  Sonia Podvin; Tony Yaksh; Vivian Hook
Journal:  Annu Rev Pharmacol Toxicol       Date:  2016       Impact factor: 13.820

9.  Cathepsin H functions as an aminopeptidase in secretory vesicles for production of enkephalin and galanin peptide neurotransmitters.

Authors:  Weiya Douglas Lu; Lydiane Funkelstein; Thomas Toneff; Thomas Reinheckel; Christoph Peters; Vivian Hook
Journal:  J Neurochem       Date:  2012-06-21       Impact factor: 5.372

10.  Cathepsin L plays a role in quinolinic acid-induced NF-Κb activation and excitotoxicity in rat striatal neurons.

Authors:  Yan-Ru Wang; Shu Qin; Rong Han; Jun-Chao Wu; Zhong-Qin Liang; Zheng-Hong Qin; Yan Wang
Journal:  PLoS One       Date:  2013-09-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.